Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gastrointestinal 19. May 2026
Search
medline.ch
Gastrointestinal
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 11990  Previews Next
   
   Articles 1 - 20 / 239795  
   
A Composite Low-Grade Inflammation Score and Cancer Outcomes: Results from the Moli-sani Study.
Cancer Epidemiol Biomarkers Prev
Costanzo S, Di Castelnuovo A, Bonaccio M, Magnacca S, Panzera T, De Curtis A, Bracone F, Martinelli G, Parisi R, Cerletti C, Donati MB, de Gaetano G, Iacoviello L.
PMID: 42154253 [PubMed - as supplied by publisher]


Short-term outcomes of self-expanding metallic stents and transanal colorectal tubes as a bridge to surgery for obstructive colon cancer: a nationwide retrospective study.
Surg Today
Tsuji H, Shigeno T, Hanaoka M, Aoyagi Y, Yamamoto Y, Yamauchi S, Kagawa H, Tokunaga M, Fushimi K, Kinugasa Y.
PMID: 42154247 [PubMed - as supplied by publisher]


Preliminary results of a prospective study on FAPi-PET for staging of locally advanced gastric cancer.
Updates Surg
Romario UF, de Pascale S, Sileo A, Cella CA, Farulla LSMA, Bertani E, Fazio N, Gervaso L, Mattana F, Ceci F.
PMID: 42154166 [PubMed - as supplied by publisher]


Disparities in Gallbladder Cancer: Epidemiology, Molecular Mechanisms, and Clinical Implications.
Mol Biol Rep
Sahoo OS, Gill GS, Nayek A, Bhardwaj N, Kurdia KC, Galodha S, Chetan R, Dhar R, Karmakar S.
PMID: 42154094 [PubMed - indexed for MEDLINE]


Dual-positive gastric cancer co-expressing AFP and CEA: an aggressive subtype defined by unique clinical and biological profiles.
Clin Exp Med
Jiang J, Liu H, Liu Y, Cao L, Gong W.
PMID: 42154089 [PubMed - as supplied by publisher]


No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trial.
J Med Screen
Dominitz JA, Robertson DJ, Miller S, Beed A, Boardman K, Del Curto B, Gupta S, Imperiale TF, Larson MF, Lieberman DA, Rosa S, Shaukat A, Sultan S, Tapia D, Kyriakides TC.
PMID: 42154016 [PubMed - as supplied by publisher]


Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer.
Radiology
Liu Z, Gu W, Liu L, Wu S, Yao Z, Sun Y, Huang D, Tong T.
PMID: 42153825 [PubMed - indexed for MEDLINE]


Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell-Cycle Control and Tumor Microenvironment Reprogramming.
Cell Biol Int
Kubina R, Morawiec ML, Nowak I, Sarna R, Krzykawski K, Kaba, Dziedzic A, Mielczarek-Palacz A, Sharifi-Rad J, Setzer WN, Calina D.
PMID: 42153606 [PubMed - indexed for MEDLINE]


Unraveling the Multifunctional and Translational Paradigm of Nanoparticulate Systems against Colorectal Cancer.
ACS Appl Bio Mater
Kumar S, Jindal A, Mainuddin, Rastogi H, Kumar A.
PMID: 42153502 [PubMed - as supplied by publisher]


Efficacy of immune checkpoint inhibitor plus chemotherapy in ARID1A-mutated advanced gastric cancer.
Ther Adv Gastroenterol
Shin JE, Lee E, Lim SH, Lee J, Kim ST.
PMID: 42153215 [PubMed]


Vitamin P Significantly Inhibits the Expression of Ki67 and VEGF and Promotes the Apoptosis of Colorectal Cancer Cells.
Iran J Pharm Res
Zhao X, Guo S, Shen R, Zhang W, Zhang Y.
PMID: 42153194 [PubMed]


Restaging pN Classification in Early Gastric Cancer with Inadequate Lymph Node Retrieval: Multi-Institutional Development and Prognostic Validation of a Revised Staging System.
Int J Gen Med
Nie X, Li G, Liu Z, Ke B, Yang Z, Ye Z, Zhang T, Wang X, Yang K, You Q, Zhou T, Li Y, Zhang R, Ren P, Wang W, Tian Y, Zhang K, Deng J.
PMID: 42153151 [PubMed]


Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.
Ther Adv Med Oncol
Arendt N, Payo-Serafín T, Kolosenko A, Kopsida M, Sjöblom M, Heindryckx F.
PMID: 42153092 [PubMed]


Kombucha tea in cancer care: A review of its anti-cancer potential and role in integrative oncology.
Avicenna J Phytomed
Sarshar M, Azmayesh L, Khoshhal F, Kabudani S, Beyrami M, Rajabian M, Moradi Binabaj M, Asgharzdaeh F.
PMID: 42153014 [PubMed]


Radiolabeled-NeoB: A Dual-Action Diagnostic and Therapeutic Agent Targeting Gastrin-Releasing Peptide Receptors in Cancer.
Curr Protein Pept Sci
Rahmati H, Mousavi SM, Jalali-Zefrei F, Farzipour S, Souri Z.
PMID: 42152655 [PubMed - as supplied by publisher]


Construction of an Extracellular Matrix-related Gene Model for Predicting Prognosis and Immune Features in Gastric Cancer.
Curr Mol Med
Xing C, Deng H, Yang C, Yang B, Wan Y, Feng J, Yu Y.
PMID: 42152648 [PubMed - as supplied by publisher]


Burden and Correlates of Multiple Chronic Infections and Their Associations With Cancer Incidence in Chinese Adults: A Large Case-Cohort Study.
Int J Cancer
Yang L, Clarke J, Kröller L, Kartsonaki C, Fry H, Jeske R, Gordon A, Clark S, Hill M, Avery D, Chen Y, Du H, Lv J, Sun D, Yu C, Li L, Millwood IY, Waterboer T, Chen Z, China Kadoorie Biobank Collaborative Group.
PMID: 42152523 [PubMed - as supplied by publisher]


DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.
J Exp Clin Cancer Res
Li F, Ling X, Chakraborty S, Tang DG, McLean K, Wu W, Sule N, Vadehra D, Fountzilas C, Gupta A, Twist C, Ohm J, Chatta G, Abrams SI.
PMID: 42152107 [PubMed - as supplied by publisher]


Validation of the biomarker toolkit using diagnostic colorectal cancer biomarkers - an evidence-based tool to support clinical adoption of biomarkers.
J Transl Med
Baggaley AE, Wu Y, Savva KV, Khan K, Gogoi P, Rafeeque H, Giot M, Siakalli M, Panayiotou C, Ni MZ, Peters CJ.
PMID: 42152068 [PubMed - as supplied by publisher]


A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial.
BMC Cancer
Banken E, Borg M, van Hellemond IEG, van Ravensteijn SG, Peulen HMU, Verrijssen AE, Nederend J, Daniels-Gooszen AW, van Oudheusden TR, van Lijnschoten G, Bloemen JG, Rutten HJT, van Westreenen HL, de Groot JWB, Verhoef C, Tanis PJ, Grotenhuis BA, Aalbers AGJ, Werter IM, Hartogh MDD, Douma JAJ, Calon TGA, Iersel LBJV, Beets GL, Tuynman JB, Intven MPW, van Kuijk SMJ, Berbée M, Buffart TE, Roodhart JML, Burger JWA, Dutch Colorectal Cancer Group.
PMID: 42151882 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 239795    Page 1 of 11990  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1